These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 26830881)

  • 21. Long-term pharmacological treatment of generalized anxiety disorder.
    Mahe V; Balogh A
    Int Clin Psychopharmacol; 2000 Mar; 15(2):99-105. PubMed ID: 10759341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The clinical course and long-term management of generalized anxiety disorder.
    Rickels K; Schweizer E
    J Clin Psychopharmacol; 1990 Jun; 10(3 Suppl):101S-110S. PubMed ID: 1973934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kava for the treatment of generalised anxiety disorder (K-GAD): study protocol for a randomised controlled trial.
    Savage KM; Stough CK; Byrne GJ; Scholey A; Bousman C; Murphy J; Macdonald P; Suo C; Hughes M; Thomas S; Teschke R; Xing C; Sarris J
    Trials; 2015 Nov; 16():493. PubMed ID: 26527536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A literature review of quetiapine for generalized anxiety disorder.
    Kreys TJ; Phan SV
    Pharmacotherapy; 2015 Feb; 35(2):175-88. PubMed ID: 25689246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The reappraisal of benzodiazepines in the treatment of anxiety and related disorders.
    Starcevic V
    Expert Rev Neurother; 2014 Nov; 14(11):1275-86. PubMed ID: 25242262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatments for generalized anxiety disorder.
    Struzik L; Vermani M; Coonerty-Femiano A; Katzman MA
    Expert Rev Neurother; 2004 Mar; 4(2):285-94. PubMed ID: 15853570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The vasopressin V(1b) receptor antagonist SSR149415 in the treatment of major depressive and generalized anxiety disorders: results from 4 randomized, double-blind, placebo-controlled studies.
    Griebel G; Beeské S; Stahl SM
    J Clin Psychiatry; 2012 Nov; 73(11):1403-11. PubMed ID: 23146246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generalized anxiety disorder: how to treat, and for how long?
    Lam RW
    Int J Psychiatry Clin Pract; 2006; 10 Suppl 1():10-5. PubMed ID: 24931538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of anxiety syndrome. A systematic literature review. Summary and conclusions by the SBU].
    von Knorring L; Thelander S; Pettersson A
    Lakartidningen; 2005 Nov 21-27; 102(47):3561-2, 3565-6, 3569. PubMed ID: 16408394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of extended-release quetiapine fumarate on long-term functioning and sleep quality in patients with Generalized Anxiety Disorder (GAD): data from a randomized-withdrawal, placebo-controlled maintenance study.
    Sheehan DV; Svedsäter H; Locklear JC; Eriksson H
    J Affect Disord; 2013 Dec; 151(3):906-13. PubMed ID: 24135509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term efficacy of pregabalin in generalized anxiety disorder.
    Feltner D; Wittchen HU; Kavoussi R; Brock J; Baldinetti F; Pande AC
    Int Clin Psychopharmacol; 2008 Jan; 23(1):18-28. PubMed ID: 18090504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Place of Antipsychotics in the Therapy of Anxiety Disorders and Obsessive-Compulsive Disorders.
    Pignon B; Tezenas du Montcel C; Carton L; Pelissolo A
    Curr Psychiatry Rep; 2017 Nov; 19(12):103. PubMed ID: 29110139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generalized anxiety disorder: comorbidity, comparative biology and treatment.
    Nutt DJ; Ballenger JC; Sheehan D; Wittchen HU
    Int J Neuropsychopharmacol; 2002 Dec; 5(4):315-25. PubMed ID: 12466031
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term management of panic disorder.
    Pollack MH
    J Clin Psychiatry; 1990 May; 51 Suppl():11-3; discussion 50-3. PubMed ID: 1970813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pregabalin long-term treatment and assessment of discontinuation in patients with generalized anxiety disorder.
    Kasper S; Iglesias-García C; Schweizer E; Wilson J; DuBrava S; Prieto R; Pitman VW; Knapp L
    Int J Neuropsychopharmacol; 2014 May; 17(5):685-95. PubMed ID: 24351233
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peripheral-type benzodiazepine receptors in anxiety disorders.
    Rocca P; Ferrero P; Gualerzi A; Zanalda E; Maina G; Bergamasco B; Ravizza L
    Acta Psychiatr Scand; 1991 Dec; 84(6):537-44. PubMed ID: 1686517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic anxiety: deciding the length of treatment.
    Gorman JM; Papp LA
    J Clin Psychiatry; 1990 Jan; 51 Suppl():11-5. PubMed ID: 1967247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generalised anxiety disorder in elderly patients : epidemiology, diagnosis and treatment options.
    Flint AJ
    Drugs Aging; 2005; 22(2):101-14. PubMed ID: 15733018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction of pharmacological and psychological treatments of anxiety.
    Lader MH; Bond AJ
    Br J Psychiatry Suppl; 1998; (34):42-8. PubMed ID: 9829016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and tolerability of extended release quetiapine fumarate monotherapy in the acute treatment of generalized anxiety disorder: a randomized, placebo controlled and active-controlled study.
    Merideth C; Cutler AJ; She F; Eriksson H
    Int Clin Psychopharmacol; 2012 Jan; 27(1):40-54. PubMed ID: 22045039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.